• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

量化免疫缺陷病患者的诊断历程负担

Quantifying the Diagnostic Odyssey Burden Among Persons with Inborn Errors of Immunity.

作者信息

Nikzad Sarina, Johnson Rebekah, Scalchunes Christopher, Rider Nicholas L

机构信息

Liberty University College of Osteopathic Medicine, Lynchburg, Virginia, USA.

Immune Deficiency Foundation, Hanover, Maryland, USA.

出版信息

J Clin Immunol. 2025 Jan 2;45(1):61. doi: 10.1007/s10875-024-01855-x.

DOI:10.1007/s10875-024-01855-x
PMID:39747782
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11695393/
Abstract

PURPOSE

Patients with inborn errors of immunity (IEI) have lifelong health complications including severe infections and physical impairments. Previous studies show that a patient's perception of their health is an important predictor of health outcomes. The purpose of this study was to understand factors related to patient reported health status.

METHODS

We used data from the Immunodeficiency Foundation (IDF) 2017 National Patient Survey and analyzed factors which correlated with the reported health status (RHS). Among a cohort of 1139 self-reported IEI patients, we identified age at the time of diagnosis, time gap between symptom onset and diagnosis, number of physicians seen, and whether the diagnosis was made in the first 5 years of life as significant. We used a two-tailed t-test, single-factor ANOVA, and Tukey-Kramer post-hoc test to assess statistical significance in the observed difference.

RESULTS

Patients who received a diagnosis before the age of 12 had a significantly better mean RHS (n = 207 pre-12a vs. n = 900 post-12a; p < 0.0001). Patients who received a diagnosis within 10 years of symptom onset showed improved mean RHS (n = 413 pre-10 vs. n = 524 post-10; p < 0.0001). Among patients who had symptom onset within the first 5 years of life, those who received a diagnosis had a significantly improved RHS (3.5 ± 0.92, n = 275 undiagnosed vs. 2.8 ± 0.94, n = 108 diagnosed; p < 0.0001). Finally, RHS was significantly impacted by number of physicians(n ≥ 4) seen prior to diagnosis (3.1 ± 0.96 vs. 3.4 ± 0.80, p < 0.0001).

CONCLUSION

These findings shed light upon critical factors which impact IEI patient RHS. Specifically, we find that efficient, rapid and early-life IEI identification should improve patient reported health and relevant outcomes. These improvements appear to be independent of the clinician specialty ultimately making the IEI diagnosis.

摘要

目的

先天性免疫缺陷(IEI)患者会面临包括严重感染和身体损伤在内的终身健康并发症。先前的研究表明,患者对自身健康的认知是健康结果的重要预测指标。本研究的目的是了解与患者报告的健康状况相关的因素。

方法

我们使用了免疫缺陷基金会(IDF)2017年全国患者调查的数据,并分析了与报告的健康状况(RHS)相关的因素。在1139名自我报告的IEI患者队列中,我们确定诊断时的年龄、症状出现与诊断之间的时间间隔、看过的医生数量以及诊断是否在生命的前5年内做出具有重要意义。我们使用双尾t检验、单因素方差分析和Tukey-Kramer事后检验来评估观察到的差异中的统计学显著性。

结果

12岁之前确诊的患者平均RHS显著更好(12岁之前确诊的患者n = 207,12岁之后确诊的患者n = 900;p < 0.0001)。症状出现后10年内确诊的患者平均RHS有所改善(症状出现后10年之前确诊的患者n = 413,症状出现后10年之后确诊的患者n = 524;p < 0.0001)。在生命的前5年内出现症状的患者中,确诊的患者RHS显著改善(未确诊的患者为3.5±0.92,n = 275;确诊的患者为2.8±0.94,n = 108;p < 0.0001)。最后,RHS受到诊断前看过的医生数量(n≥4)的显著影响(3.1±0.96 vs. 3.4±0.80,p < 0.0001)。

结论

这些发现揭示了影响IEI患者RHS的关键因素。具体而言,我们发现高效、快速和早期的IEI识别应该会改善患者报告的健康状况和相关结果。这些改善似乎与最终做出IEI诊断的临床医生专业无关。

相似文献

1
Quantifying the Diagnostic Odyssey Burden Among Persons with Inborn Errors of Immunity.量化免疫缺陷病患者的诊断历程负担
J Clin Immunol. 2025 Jan 2;45(1):61. doi: 10.1007/s10875-024-01855-x.
2
The Spectrum of Inborn Errors of Immunity in the United Arab Emirates: 5 Year Experience in a Tertiary Center.阿拉伯联合酋长国先天性免疫缺陷疾病谱:三级医疗中心的5年经验
Front Immunol. 2022 Jan 31;13:837243. doi: 10.3389/fimmu.2022.837243. eCollection 2022.
3
Implementation of Early Next-Generation Sequencing for Inborn Errors of Immunity: A Prospective Observational Cohort Study of Diagnostic Yield and Clinical Implications in Dutch Genome Diagnostic Centers.实施先天性免疫缺陷的新一代测序:荷兰基因组诊断中心前瞻性观察队列研究的诊断收益和临床意义。
Front Immunol. 2021 Dec 21;12:780134. doi: 10.3389/fimmu.2021.780134. eCollection 2021.
4
Invasive fungal disease in a large cohort of hospitalized children with inborn errors of immunity in China.中国一大群患有先天性免疫缺陷的住院儿童中的侵袭性真菌病。
Pediatr Allergy Immunol. 2025 Apr;36(4):e70074. doi: 10.1111/pai.70074.
5
Needs for Increased Awareness of Gastrointestinal Manifestations in Patients With Human Inborn Errors of Immunity.提高对人类先天性免疫缺陷患者胃肠道表现认识的必要性。
Front Immunol. 2021 Aug 12;12:698721. doi: 10.3389/fimmu.2021.698721. eCollection 2021.
6
Allogeneic Hematopoietic Stem Cell Transplantation Activity in Inborn Errors of Immunity in Russian Federation.俄罗斯联邦先天性免疫缺陷疾病的异基因造血干细胞移植活动。
J Clin Immunol. 2023 Aug;43(6):1241-1249. doi: 10.1007/s10875-023-01476-w. Epub 2023 Apr 3.
7
Validating inborn error of immunity prevalence and risk with nationally representative electronic health record data.利用具有全国代表性的电子健康记录数据验证先天免疫缺陷的患病率和风险。
J Allergy Clin Immunol. 2024 Jun;153(6):1704-1710. doi: 10.1016/j.jaci.2024.01.011. Epub 2024 Jan 24.
8
Coronavirus disease 2019 in patients with inborn errors of immunity: An international study.先天性免疫缺陷患者的 2019 年冠状病毒病:一项国际研究。
J Allergy Clin Immunol. 2021 Feb;147(2):520-531. doi: 10.1016/j.jaci.2020.09.010. Epub 2020 Sep 24.
9
Consensus Middle East and North Africa Registry on Inborn Errors of Immunity.共识中东和北非先天性免疫缺陷登记处。
J Clin Immunol. 2021 Aug;41(6):1339-1351. doi: 10.1007/s10875-021-01053-z. Epub 2021 May 29.
10
The multidisciplinary approach to diagnosing inborn errors of immunity: a comprehensive review of discipline-based manifestations.多学科方法诊断先天性免疫缺陷:基于学科的表现的综合综述。
Expert Rev Clin Immunol. 2024 Oct;20(10):1237-1259. doi: 10.1080/1744666X.2024.2372335. Epub 2024 Jul 2.

本文引用的文献

1
Validating inborn error of immunity prevalence and risk with nationally representative electronic health record data.利用具有全国代表性的电子健康记录数据验证先天免疫缺陷的患病率和风险。
J Allergy Clin Immunol. 2024 Jun;153(6):1704-1710. doi: 10.1016/j.jaci.2024.01.011. Epub 2024 Jan 24.
2
Self-rated physical health predicts mortality in aging persons beyond objective health risks.自评身体健康状况可预测老年人的死亡率,超出客观健康风险因素的预测。
Sci Rep. 2023 Nov 9;13(1):19531. doi: 10.1038/s41598-023-46882-7.
3
Natural history of infants with non-SCID T cell lymphopenia identified on newborn screen.新生儿筛查中发现的非 SCID T 细胞减少症婴儿的自然史。
Clin Immunol. 2022 Dec;245:109182. doi: 10.1016/j.clim.2022.109182. Epub 2022 Nov 8.
4
A validated artificial intelligence-based pipeline for population-wide primary immunodeficiency screening.一种经过验证的基于人工智能的全人群原发性免疫缺陷筛查流程。
J Allergy Clin Immunol. 2023 Jan;151(1):272-279. doi: 10.1016/j.jaci.2022.10.005. Epub 2022 Oct 13.
5
Current Transition Practice for Primary Immunodeficiencies and Autoinflammatory Diseases in Europe: a RITA-ERN Survey.欧洲原发性免疫缺陷和自身炎症性疾病的现行过渡实践:RITA-ERN 调查。
J Clin Immunol. 2023 Jan;43(1):206-216. doi: 10.1007/s10875-022-01345-y. Epub 2022 Oct 12.
6
Quality of Life and Social and Psychological Outcomes in Adulthood Following Allogeneic HSCT in Childhood for Inborn Errors of Immunity.儿童先天性免疫缺陷异基因 HSCT 后成年期生活质量和社会心理结局
J Clin Immunol. 2022 Oct;42(7):1451-1460. doi: 10.1007/s10875-022-01286-6. Epub 2022 Jun 20.
7
Evaluation of the 10 Warning Signs in Primary and Secondary Immunodeficient Patients.原发性和继发性免疫缺陷患者 10 大警示征象评估。
Front Immunol. 2022 May 13;13:900055. doi: 10.3389/fimmu.2022.900055. eCollection 2022.
8
A single screen-printed electrode in tandem with chemometric tools for the forensic differentiation of Brazilian beers.串联单丝网印刷电极与化学计量学工具用于巴西啤酒的法医鉴别。
Sci Rep. 2022 Apr 4;12(1):5630. doi: 10.1038/s41598-022-09632-9.
9
Health-Related Quality of Life in 91 Patients with X-Linked Agammaglobulinemia.91 例 X 连锁无丙种球蛋白血症患者的健康相关生活质量。
J Clin Immunol. 2022 May;42(4):811-818. doi: 10.1007/s10875-022-01222-8. Epub 2022 Mar 14.
10
Cross-classification between self-rated health and health status: longitudinal analyses of all-cause mortality and leading causes of death in the UK.自评健康与健康状况的交叉分类:英国全因死亡率和主要死因的纵向分析。
Sci Rep. 2022 Jan 10;12(1):459. doi: 10.1038/s41598-021-04016-x.